Different expression of some molecular markers in sporadic cancer of the left and right colon

被引:29
|
作者
Fric, P [1 ]
Sovová, V
Sloncová, E
Lojda, Z
Jirásek, A
Cermák, J
机构
[1] Cent Mil Hosp, Prague 16902 6, Czech Republic
[2] Postgrad Inst Med, Prague 16902 6, Czech Republic
[3] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic
[4] Charles Univ, Lab Histochem, Prague, Czech Republic
[5] Charles Univ, Inst Hematol, Prague, Czech Republic
[6] Charles Univ, Inst Pathol 1, Prague, Czech Republic
[7] Charles Univ, Dept Surg 1, Prague, Czech Republic
关键词
left and right colon; ontogenesis; protooncogenes and DPP IV expression; sporadic cancer;
D O I
10.1097/00008469-200008000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of cytoplasmic c-erbB2, epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and dipeptidylpeptidase IV (DPP IV) was significantly higher in sporadic cancer of the right than of the left colon. In addition, cytoplasmic c-erbB2 displayed the same difference in the adjacent (less than 2 cm) and distant (more than 5 cm from the tumour margin) mucosa. The findings cannot be related to Dukes staging. It is suggested that different ontogenic development of the right (from the midgut) and the left (from the hindgut) colon may be a possible explanation. Therefore, data on the expression of different molecular markers in colorectal cancer and surrounding mucosa should always be supplemented by data on tumour location. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 50 条
  • [41] Right Versus Left Colon Cancer: Resectable and Metastatic Disease
    Michele Ghidini
    Fausto Petrelli
    Gianluca Tomasello
    Current Treatment Options in Oncology, 2018, 19
  • [42] MOLECULAR MARKERS OF PROGNOSIS AND INDIVIDUALISATION OF COLON CANCER TREATMENT
    Navruzov, S. N.
    Pulatov, D. A.
    Ibragimov, J. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E28 - E28
  • [43] Molecular markers that predict response to colon cancer therapy
    Ahmed, FE
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (03) : 353 - 375
  • [44] Molecular markers to individualize adjuvant therapy for colon cancer
    Gangadhar, Tara
    Schilsky, Richard L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 318 - 325
  • [45] Molecular prognostic markers in locally advanced colon cancer
    Lurje, Georg
    Zhang, Wu
    Lenz, Heinz-Josef
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 683 - 690
  • [46] Molecular and clinical risk markers in colon cancer trials
    Hill, MJ
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (10) : 1288 - 1291
  • [47] Molecular markers to individualize adjuvant therapy for colon cancer
    Tara Gangadhar
    Richard L. Schilsky
    Nature Reviews Clinical Oncology, 2010, 7 : 318 - 325
  • [48] Different treatment strategies and molecular features between right-sided and left-sided colon cancers
    Shen, Hong
    Yang, Jiao
    Huang, Qing
    Jiang, Meng-Jie
    Tan, Yi-Nuo
    Fu, Jian-Fei
    Zhu, Li-Zhen
    Fang, Xue-Feng
    Yuan, Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (21) : 6470 - 6478
  • [49] Different treatment strategies and molecular features between right-sided and left-sided colon cancers
    Hong Shen
    Jiao Yang
    Qing Huang
    Meng-Jie Jiang
    Yi-Nuo Tan
    Jian-Fei Fu
    Li-Zhen Zhu
    Xue-Feng Fang
    Ying Yuan
    World Journal of Gastroenterology, 2015, (21) : 6470 - 6478
  • [50] Molecular Staging: Integration of Molecular Prognostic Markers into Staging of Colon Cancer
    Hayashi, Shinichi
    Jass, Jeremy R.
    CURRENT COLORECTAL CANCER REPORTS, 2005, 1 (02) : 85 - 90